Dr. Kalali is a physician-scientist, recognized globally as a leading innovator at the intersection of life sciences and technology, and a convener of collaborative high-impact forums. He is a board director of both private and publicly traded companies, and advises companies in the life sciences and technology sectors, universities, and investment groups. Dr. Kalali is the Co-Chair of the Decentralized Trials and Research Alliance (DTRA), Chairman and Chief Curator of the CNS Summit, a forum focused on the future of life sciences, and was the Founding Chairman, and sits on the Executive Committee of the International Society for CNS Drug Development (ISCDD), one of the first independent non-profits to bring together leaders in drug development to collaborate. He is a Professor of Psychiatry at the University of California San Diego, Editor of the journal Innovations in Clinical Neuroscience, and the Lead Editor of the book Essential CNS Drug Development., published by Cambridge University Press. He has authored over 250 peer-reviewed publications, and numerous book chapters. He has been involved in initiatives by the Institute of Medicine, as well as the NIH FAST and the NIH NCATS programs. Previously, for almost 20 years, he was the Global Head of the Neuroscience Center of Excellence at Quintiles, now known as IQVIA. In this role, he led the enterprise-wide strategy for neuroscience, encompassing drug development and health care services. He was responsible for numerous successful drug development programs that have led to dozens of approved new treatments for patients. Dr. Kalali regularly speaks at national and international scientific meetings on topics including leadership, drug development, clinical trials, innovation, technology, digital medicine, biohacking, and health.

Bio coming soon

Bio coming soon

Patrick Lee is a Senior Manager for the Digital Medicine team at Amgen, where he brings his DCT experience to build and scale Amgen's DCT capabilities. Prior to his current role, Patrick worked in various leadership positions within Amgen's Clinical Program Operations team, driving innovative protocol design for Inflammation and Oncology programs, designing a new data and insights-driven feasibility process, and helping to build a new patient recruitment and retention function - the Enrollment Lab.

Patrick's clinical research career began in 2017 as a Clinical Research Coordinator at Science 37, where he worked on the company's first fully DCT study with AOBiome. During his time at Science 37, Patrick helped to set up data management processes, served as a clinical SME to develop the company's NORA platform, and led several fully virtual and hybrid studies as a Clinical Project Manager. After his tenure at Science 37, Patrick joined the newly-formed Lightship in 2020 as the company's first Clinical Project Manager, overseeing the company's first DCT study with Verily and Pfizer and helping to build the Clinical Operations team.

Patrick earned his Bachelor's degree in Molecular and Cell Biology - Neurobiology from the University of California, Berkeley, and his Ph.D. in Molecular and Medical Pharmacology from the David Geffen School of Medicine at UCLA, where his research focused on autologous cellular replacement therapies using CRISPR-modified human induced pluripotent stem cells to treat rare diseases. He has had 10 years of basic science experience - starting off his career in 2009 in the Microbial Pathogenesis department at Genentech and beginning his stem cell training at Stanford University's Institute of Stem Cell Biology and Regenerative Medicine.

Bio coming soon

Bio coming soon

Bio coming soon

Bio coming soon

Bio coming soon

Becky Kottschade is an experienced clinical research administrator with more than 20 years of experience in the field. Driven by her commitment to Mayo Clinic's primary value, the needs of the patient come first, Becky takes pride in leading the effort of defining best practice in how to successfully implement decentralized clinical trial capabilities from concept to large scale adoption. In her role as research administrator, she is focused on providing streamlined solutions and associated best practices for both people, process and technology improvements that allow researchers and study teams to provide the best care for patients on trial. In addition to her primary functions as an administrator, Becky has been recognized for her extraordinary commitment to relationship building, solutions-oriented excellence in customer service and leading teams through transformational changes at Mayo Clinic.

With a background in information systems and clinical research experience spanning over 20 years, Rick has enjoy working to build and implement solutions for this exciting and challenging industry. He invented RealTime-CTMS to solve many of the daily challenges that face clinical research sites, and his team is working on many innovative software solutions that will continue to create efficiencies for sites and the entities that interface with them. There is an exciting future ahead for the clinical research industry as technology will soon accelerate the evolution of methods that streamline data processing and communication between sites, CROs, Sponsors, IRBs and other important vendors. Collaboration and standardization will be the keys to our mutual success in this endeavor.

Bio coming soon

Bio coming soon

Angela Radcliffe is a best-selling author, speaker, and advocate for teaching health, data and Al literacy. Drawing on 20+ years of experience centered around healthcare innovation, Angela combines deep Al healthcare expertise with authentic storytelling to engage diverse audiences and empower children and teens to succeed in a data-centric world. Driven by the preventable loss of her 21-year-old brother to an undiagnosed heart condition, Angela champions health literacy while navigating the complexities of raising three children across different technological generations, including a neurodivergent learner. This unique intersection of personal tragedy and parenting challenges and her journey from poverty to escaping domestic violence fuels her mission to advance health, data, and Al literacy for the next generation.